Pilot Study of Anti-Th2 Immunotherapy for the Treatment of Breast Cancer-Related Upper Extremity Lymphedema

SIMPLE SUMMARY: Lymphedema is a common complication of cancer, and patients with lymphedema have substantially decreased quality of life and suffer from lifelong symptoms. This study aimed to examine the effect of inhibition of Th2 inflammation in lymphedema by using QBX258, a combination of IL4/13...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehrara, Babak J., Park, Hyeung Ju, Kataru, Raghu P., Bromberg, Jacqueline, Coriddi, Michelle, Baik, Jung Eun, Shin, Jinyeon, Li, Claire, Cavalli, Michele R., Encarnacion, Elizabeth M., Lee, Meghan, Van Zee, Kimberly J., Riedel, Elyn, Dayan, Joseph H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466465/
https://www.ncbi.nlm.nih.gov/pubmed/34571811
http://dx.doi.org/10.3390/biology10090934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466465/
https://www.ncbi.nlm.nih.gov/pubmed/34571811
http://dx.doi.org/10.3390/biology10090934

Ejemplares similares